Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02265341
Title Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Mayo Clinic
Indications

biliary tract cancer

Therapies

Ponatinib

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST